脓毒症时宿主肺内源性Caveolin-1表达下调以促进细胞保护
本研究在盲肠结扎穿孔(CLP)脓毒症模型中观察肺组织内源性Caveolin-1蛋白表达谱,用流式细胞术和免疫组化检测Caveolin-1、CD25、pP38、pAkt和14-3-3b在脓毒症诱导后6、12、24、36、48小时的表达,用7-AAD染色测细胞活力、Masson三色染色测纤维化。CLP处理增加肺部炎症和细胞凋亡,血管和肺泡可见纤维化,Caveolin-1阳性细胞蛋白表达降低,尤以CLP后12小时明显(P=0.002)。给予蛋白C酶原浓缩物后细胞凋亡减少(P=0.004),Caveolin-1阳性细胞百分位和表达强度均受影响(分别为P=0.009和P=0.027),14-3-3b、CD25和pP38蛋白表达降低(分别为P=0.014、P=0.004和P=0.007),而pAkt表达被诱导(P=0.032)。作者认为脓毒症期间内源性Caveolin-1蛋白表达下降提示其参与宿主细胞保护反应,可能直接通过控制小窝数量减少细菌负荷,或间接通过调节14-3-3b依赖的凋亡和EPCR-PAR-1依赖的保护信号。
要点
- CLP脓毒症模型中肺组织Caveolin-1阳性细胞蛋白表达降低,CLP后12小时最明显(P=0.002)。
- CLP后肺部炎症和细胞凋亡增加,血管和肺泡出现纤维化,pP38阳性细胞群早期诱导(P=0.014),CD25阳性细胞逐渐增加。
- 给予蛋白C酶原浓缩物后细胞凋亡减少(P=0.004),Caveolin-1阳性细胞百分位和表达强度受影响(P=0.009和P=0.027)。
- 蛋白C酶原浓缩物使14-3-3b、CD25和pP38蛋白表达降低(P=0.014、P=0.004和P=0.007),pAkt表达被诱导(P=0.032)。
- 作者认为内源性Caveolin-1表达下降参与宿主细胞保护反应,可能直接控制小窝数量减少细菌负荷或间接调节14-3-3b依赖凋亡和EPCR-PAR-1依赖保护信号。
适用人群与场景
- CLP脓毒症模型小鼠,观察肺组织内源性Caveolin-1蛋白表达谱及蛋白C酶原浓缩物干预效果。
处置流程与药物剂量
- 蛋白C酶原浓缩物(PC)给药:原文未写明剂量、途径、频次和疗程。
研究设计与关键结果
- 研究类型:动物实验(CLP脓毒症模型),检测时间点为脓毒症诱导后6、12、24、36、48小时。
- CLP处理增加肺部炎症和细胞凋亡,血管和肺泡可见纤维化。
- Caveolin-1阳性细胞蛋白表达降低,CLP后12小时最明显(P=0.002)。
- 免疫组化显示Caveolin-1阳性表达主要位于炎症反应强烈区域。
- 早期诱导pP38阳性细胞群(P=0.014),CD25阳性细胞逐渐增加。
- 14-3-3b表达改变与凋亡相关,脓毒症进展后期伴随AKT磷酸化活性增加。
- 给予蛋白C酶原浓缩物后细胞凋亡减少(P=0.004),Caveolin-1阳性细胞百分位和表达强度均受影响(P=0.009和P=0.027)。
- 蛋白C酶原浓缩物使14-3-3b、CD25和pP38蛋白表达降低(P=0.014、P=0.004和P=0.007),pAkt表达被诱导(P=0.032)。
证据类型、等级与局限
- 证据类型:动物实验(CLP脓毒症模型)。
- 局限:原文未报告局限性。
对床旁实践的改变
- 原文未据此给出推荐。
提炼说明
- 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开
The present study focuses on the profile of "endogeneous" caveolin-1 protein in septic lung (CLP model).Caveolin-1, CD25, pP38, pAkt, and 14-3-3b protein expression profiles were studied using flow cytometry and immunohistochemistry 6, 12, 24, 36, and 48 h after sepsis induction. Cell viability was determined by 7-AAD staining and fibrosis by Masson trichrome stain. The effect of protein C zymogen concentrate (PC) on caveolin-1 expression was also investigated given that PC, once dissociated from caveolin-1, elicits a PAR-1-mediated protective signaling by forming a complex with endothelial protein C receptor (EPCR).CLP treatment increased lung inflammation and cell apoptosis. Fibrosis was apparent in vessels and alveoli. Caveolin-1+ cells presented reduced protein expression, especially 12 h post-CLP (P = 0.002). Immunohistochemistry revealed caveolin-1 positive expression mainly in regions with strong inflammatory reaction. Early induction of pP38+ cell population (P = 0.014) and gradual increase of CD25+ cells were also observed. Alternations in 14-3-3b expression related to apoptosis were apparent and accompanied by increased AKT phosphorylation activity late during sepsis progression.After PC administration, cell apoptosis was reduced (P = 0.004) and both the percentile and expression intensity of caveolin-1 positive cells were compromised (P = 0.009 and P = 0.027, respectively). 14-3-3b, CD25, and pP38 protein expression were decreased (P = 0.014, P = 0.004, and P = 0.007, respectively), whereas pAkt expression was induced (P = 0.032).The observed decline of endogenous caveolin-1 protein expression during sepsis implies its involvement in host's cytoprotective reaction either directly, by controlling caveolae population to decrease bacterial burden, or indirectly via regulating 14-3-3b-dependent apoptosis and EPCR-PAR-1-dependent protective signaling.
参考来源
- Kataki A, Karagiannidis I, Memos N, et al. Host's Endogenous Caveolin-1 Expression is Downregulated in the Lung During Sepsis to Promote Cytoprotection. Shock. 2018. PMID: 28957875. doi:10.1097/SHK.0000000000001005
供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。